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ABSTRACT 
Excessive use of oestrogen or ethinyl oestradiol (EO, a semisynthetic 17b-oestradiol as highly potent oestrogen) can cause many detrimental effects, including 
cancer in humans as well as in animals. On the other hand, many herbal drugs are beneficial for the treatment of toxicity and cancer. Likewise, ProImmu and 
its plant-ingredients have been reported to possess immunomodulatory effect and restore the normal histoarchitecture of the damaged tissues. In the present 
study, the beneficial effects of ProImmu, and its two ingredients, viz., Tinospora cordifolia and Withania somnifera have been observed against EO altered 
haematological profiles in the female albino rats. The haematological study showed that EO (@ 250 μg/kg, orally, thrice a week) altered levels of haemoglobin 
(Hb), total leucocyte count (TLC) and differential leucocyte count (DLC- lymphocyte, monocyte, neutrophil and eosinophil) could be significantly normalized 
by ProImmu (@ 150 mg/kg, orally, daily for 8 weeks); however, the normalization of these parameters brought up by T. cordifolia (@ 250 mg/kg, orally, daily 
for 8 weeks) and W. somnifera (@ 250 mg/kg, orally, daily for 8 weeks) was found to be of lesser degree. ProImmu (@150 mg/kg, orally, daily for 12 weeks), 
T. cordifolia (@250 mg/kg, orally, daily for 12 weeks) and W. somnifera (@ 250 mg/kg, orally, daily for 12 weeks) also caused the normalcy of these 
parameters, but to less extent than observed on the 8 weeks.  
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INTRODUCTION 
Oestrogen has been stated to cause many detrimental effects 
both in humans  and  animals.  The  over  doses  of  oestrogen 
may cause nausea, vomiting, anorexia, migraine, blurring of 
vision, mental depression, headache, asthma, endometriosis, 
fibroids,  breast  engorgement,  increased  vaginal  secretion, 
oedema, cardiovascular and hepatic diseases, cancer, stroke, 
Alzheimer’s  disease,  and  many  others  in  human  beings
1-3. 
Synthetic oestrogen, hexoestrol (60 mg/kg, orally, daily up to 
40 days) is hepatotoxic in female rats
4. All the rats showed 
reduction  in  body  weight  and  appetite,  and  gain  in  liver 
weight. This latter effect was due to both cellular hypertrophy 
and  hyperplasia.  The  adverse  effects  like  bone  marrow 
suppression,  pyometra  and  infertility  in  bitches  after 
treatment  with  many  oestrogen  preparations
5.  Oestrogen 
caused lethargy, anorexia and collapse with clinical findings, 
including  vaginal  discharge,  endometritis  and  enlarged 
mammary  glands  in  bitches
6.  Ethinyl  oestradiol  (EO,  a 
semisynthetic  17b-oestradiol  which  is  highly  potent 
oestrogen) in doses of 250, 500 and 750 μg/kg, orally, weekly 
has been reported to cause uterine and ovarian cytotoxicity 
and cancer in albino rats
3. 
Several  ethnomedicinal  plants  and  their  preparations  are 
being  used  for  prevention  and  treatment  of  cytotoxicity 
caused by various toxicants. According to WHO estimates, 
more than 80% people depend on autochthonous herbal drugs 
for  their  primary  health  needs
7.  ProImmu  (a  herbal  drug 
manufactured by Indian Herbs Research & Supply Co. Ltd., 
Saharanpur,  UP),  which    contains  Tinospora  cordifolia 
(Giloe),  Withania  somnifera  (Ashwagandha),  Ocimum 
sanctum  (Tulsi)  and  Emblica  officinalis  (Amla),  has  been 
reported to possess immunomodulatory effect and restore the 
normal histoarchitecture of the damaged tissues
3,8. Cytogenic 
effect  of  ProImmu  has  been  observed  against  EO  induced 
damage in the uterine tissues of rat
9.  
In view of above facts, the present study was undertaken to 
evaluate the beneficial effects of three herbal drugs, viz., T. 
cordifolia,  W.  somnifera  and  ProImmu  against  EO 
(oestrogen)  induced  haematological  alteration  in  female 
albino rats.  
 
MATERIALS AND METHODS 
To  evaluate  the  beneficial  effects  of  herbal  drugs  T. 
cordifolia,  W.  somnifera  and  ProImmu,  fifty  four  female 
albino rats were used in the study. Rats were divided into 9 
groups, each consisted of six rats. The rats of group 1 were 
administered  with normal  saline  to  serve  as normal group. 
EO (250 μg/kg, orally, thrice a week) was administered in 
groups 2 to 5 and groups 6 to 9 of rats for 8 and 12 weeks, 
respectively. However, the hydroalcoholic extract (HAE) of 
T. cordifolia (250 mg/kg, orally, daily), HAE of W. somnifera 
(250  mg/kg,  orally,  daily)  and  aqueous  suspension  of 
ProImmu  powder  (150  mg/kg,  orally,  daily)  were 
administered to the rats of groups 3 to 5, respectively for 8 
weeks. Similarly, these three herbal drugs at the same dose 
rate  were  administered  to  the  rats  of  groups  7  to  9, 
respectively for 12 weeks.    
After end of the experiment, the haematological study in the 
blood samples of all the rats was conducted. The blood was 
collected from the eye veins (Intraocular method) of rats. The 
haematological  parameters,  viz.,  Hb,  TLC  and  DLC  (viz., 
lymphocyte, monocyte, neutrophil, eosinophil and basophil) 
have been estimated according to the methods described by 
Jain
10.  For  statistical  analysis,  the  data  of  each  parameter 
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determined by employing the Duncan’s new multiple range 
test at P = 0.05 (5% level of significance)
11. 
 
 
Table 1: Effect of T. cordifolia, W. somnifera and ProImmu on Hb, TLC and lymphocyte in ethinyl oestradiol induced damage in rat 
Group  Treatment  Week of 
experiment 
Hb Mean
** 
±S.E. (g/dl) 
TLC Mean
** 
±S.E. (10
3/µl) 
Lymphocyte 
Mean
** ±S.E. (%) 
 
1 
 
2 
 
3 
 
 
4 
 
 
5 
 
 
6 
 
7 
 
 
8 
 
 
9 
 
 
Normal saline 
 
EO @ 250 μg/kg, orally, thrice a week for 8 weeks 
 
EO according to group 2 and T. cordifolia @ 250 mg/kg, 
orally, daily for 8 weeks from the start of experiment 
 
EO according to group 2 and W. somnifera @ 250 mg/kg, 
orally, daily for 8 weeks from the start of experiment 
 
EO according to group 2 and ProImmu @ 150 mg/kg, orally, 
daily for 8 weeks from the start of experiment 
 
EO @ 250 μg/kg, orally, thrice a week for 12 weeks 
 
EO according to group 6 and T. cordifolia @ 250 mg/kg, 
orally, daily for 12 weeks from the start of experiment 
 
EO according to group 6 and W. somnifera @ 250 mg/kg, 
orally, daily for 12 weeks from the start of experiment 
 
EO according to group 6 and ProImmu @ 150 mg/kg, orally, 
daily for 12 weeks from the start of experiment 
 
1
st 
 
9
th 
 
9
th 
 
 
9
th 
 
 
9
th 
 
 
13
th 
 
13
th 
 
 
13
th 
 
 
13
th 
 
 
13.7
a±1.4 
 
10.0
b±0.3 
 
12.5
a±0.2 
 
 
12.6
a±0.2 
 
 
13.0
a±0.3 
 
 
7.8
c±0.3 
 
12.0
a±0.2 
 
 
12.3
a±0.2 
 
 
12.8
a±0.3 
 
7766.7
a±647.9
 
 
3800.0
d±57.7 
 
5866.7
bc±566.1 
 
 
6316.7
abc±6892 
 
 
7300.0
ab±587.7 
 
 
3150.0
d±76.4 
 
5300.0
c±258.2 
 
 
5716.7
bc±463.6 
 
 
6483.3
abc±489.9 
 
 
 
36.8
a ±1.0 
 
26.3
ef±0.9 
 
31.5
cd±0.8 
 
 
33.0
bcd±0.82 
 
 
35.5
ab±1.1 
 
 
20.0
f±0.6 
 
29.5
de±1.2 
 
 
30.0
de±0.9 
 
 
34.5
abc±0.8 
*Number of animals in each group=6. 
**Mean with same superscript does not differ significantly (Duncan’s new multiple range test at P=0.05). 
 
Table 2: Effect of T. cordifolia, W. somnifera and ProImmu on monocyte, neutrophil and eosinophil  in ethinyl oestradiol induced damage in rat 
Group
*  Treatment  Week of 
experiment 
Monocyte 
Mean
** ±S.E. (%) 
Neutrophil 
Mean
** ±S.E. (%) 
Eosinophil 
Mean
** ±S.E. (%) 
 
1 
 
2 
 
3 
 
 
4 
 
 
5 
 
 
6 
 
7 
 
 
8 
 
 
9 
 
 
Normal saline 
 
EO @ 250 μg/kg, orally, thrice a week for 8 weeks 
 
EO according to group 2 and T. cordifolia @ 250 mg/kg, 
orally, daily for 8 weeks from the start of experiment 
 
EO according to group 2 and W. somnifera @ 250 mg/kg, 
orally, daily for 8 weeks from the start of experiment 
 
EO according to group 2 and ProImmu @ 150 mg/kg, 
orally, daily for 8 weeks from the start of experiment 
 
EO @ 250 μg/kg, orally, thrice a week for 12 weeks 
 
EO according to group 6 and T. cordifolia @ 250 mg/kg, 
orally, daily for 12 weeks from the start of experiment 
 
EO according to group 6 and W. somnifera @ 250 mg/kg, 
orally, daily for 12 weeks from the start of experiment 
 
EO according to group 6 and ProImmu @ 150 mg/kg, 
orally, daily for 12 weeks from the start of experiment 
 
1
st 
 
9
th 
 
9
th 
 
 
9
th 
 
 
9
th 
 
 
13
th 
 
13
th 
 
 
13
th 
 
 
13
th 
 
 
7.0
a±0.4 
 
1.5
f±0.2 
 
3.5
cde±0.4 
 
 
4.2
bcd±0.6 
 
 
5.5
b±0.4 
 
 
1.3
f±0.2 
 
2.3
ef±0.2 
 
 
3.3
de± 0.5 
 
 
4.7
bc±0.4 
 
63.3
a±2.5 
 
37.0
d±0.5 
 
49.2
c±0.8 
 
 
54.8
b±2.5 
 
 
61.0
a±1.2 
 
 
31.2
e±1.1 
 
45.3
c±1.7 
 
 
47.0
c±1.7 
 
 
56.8
b±1.9 
 
4.1
e±0.5 
 
6.5
b±0.4 
 
5.0
cde±0.6 
 
 
4.8
cde±0.3 
 
 
4.3
de±0.3 
 
 
8.0
a±0.4 
 
6.0
bc±0.4 
 
 
5.5
bcd±0.2 
 
 
4.5
de±0.4 
*Number of animals in each group=6. 
**Mean with same superscript does not differ significantly (Duncan’s new multiple range test at P=0.05). 
 
RESULTS AND DISCUSSION 
The  Hb  concentrations,  TLC  and  lymphocyte  counts 
observed in the rats of groups 1 to 9 are presented in Table 1. 
The  Hb  values  of  groups  1,  5,  9,  4,  3,  8  and  7  did  not 
decrease  significantly  (P<0.05)  and  found  non-significant 
with  each  other.  However,  the  Hb  values  of  these  groups 
decreased significantly with groups 2 and 6. The Hb values 
of  groups  2  and  6  also  decreased  significantly  with  each 
other. The per cent decrease in the Hb values was found to be 
27.0, 8.8, 8.0, 5.1, 43.1, 12.4, 10.2 and 6.6 in groups 2 to 9, 
respectively  as  compared  to  group  1.  There  was  found no 
significant difference amongst the TLC values of groups 1, 5, 
9 and 4; groups 5, 9, 4, 3 and 8; groups 9, 4, 3, 8 and 7; 
groups  2  and  6.  However,  the  TLC  value  differed 
significantly (P<0.05) in the remaining groups, viz., group 1 
with group 3, 8, 7, 2 and 6; group 5 with groups 7, 2 and 6; 
groups  9, 4, 3, 8 and 7 with groups 2 and 6. The per cent 
decrease in the TLC values was found to be 51.1, 24.5, 18.7, 
6.0, 59.4, 31.8, 26.4 and 16.0 in groups 2 to 9, respectively as 
compared to group 1. The lymphocyte values of groups 1, 5 
and 9 did not decrease significantly (P<0.05) and found non-
significant with each other. Similarly, the lymphocyte value 
of groups 5, 9 and 4 did not decrease significantly with each 
other; whilst such values of groups 9, 4 and 3; groups 4, 3, 8 
and 7; groups 8, 7 and 2; groups 2 and 6 did not decrease 
significantly  with  each  other.  However,  the  lymphocyte Govind Pandey et al. IRJP 2012, 3 (12) 
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values of group 1 with groups 4, 3, 8, 7, 2 and 6; group 5 
with groups 3, 8, 7, 2 and 6; group 9 with groups 8, 7, 2 and 
6; groups 4 and 3 with groups 2 and 6; groups 8 and 7 with 
group 6 differed significantly (P<0.05). The per cent decrease 
in the lymphocyte values was found to be 28.5, 14.4, 10.3, 
3.5, 45.7, 19.8, 18.5 and 6.3 in groups 2 to 9, respectively as 
compared to group 1. 
The  concentrations  (%)  of  monocyte,  neutrophil  and 
eosinophil estimated in the rats of groups 1 to 9 are depicted 
in  Table  2.  The  monocyte  value  of  group  1  differed 
significantly (P<0.05) with those of groups 2 to 9. Amongst 
the latter groups, the monocyte values differed significantly 
as under: group 5 with groups 3, 8, 7, 2 and 6; group 9 with 
groups 8, 7, 2, 6; group 4 with groups 7, 2, and 6; groups 3 
and 8 with groups 2 and 6; groups 2 and 6 with all other 
groups  except  group  7.  However,  there  was  no  significant 
difference  amongst  the  remaining  groups.  The  per  cent 
decrease in the monocyte values was found to be 78.6, 50.0, 
40.0,  21.4,  81.4,  67.1,  52.9  and  32.6  in  groups  2  to  9, 
respectively as compared to group 1. The neutrophil values of 
groups 1 and 5 decreased significantly (P<0.05) in all other 
groups.  Similarly,  such  values  of  groups  9  and  4  differed 
significantly with groups 3, 8, 7, 2 and 6; while the neutrophil 
values of groups 3, 8 and 7 differed significantly with groups 
2  and  6.  There  was  also  found  a  significant  difference 
between  the  neutrophil  values  of  groups  2  and  6.  The 
neutrophil values of groups 1 and 5; groups 9 and 4; groups 
3, 8 and 7 did not differ significantly with each other. The per 
cent decrease in the neutrophil values was found to be 41.5, 
22.3, 13.4, 3.6, 50.7, 28.4, 24.6 and 10.3 in groups 2 to 9, 
respectively as compared to group 1. The eosinophil values 
of group 1 increased significantly (P<0.05) in groups 8, 7, 2 
and 6. Such value of group 6 decreased significantly in all 
other  groups.  There  was  found  no  significant  difference 
amongst the  eosinophil  values  of  groups  1,  5,  9,  4 and  3; 
groups 5, 9, 4, 3 and 8; groups 4, 3, 8 and 7; groups 8, 7 and 
2. The per cent increase in the eosinophil values was found to 
be 58.5, 21.9, 17.0, 12.2, 95.1, 46.3, 34.1 and 9.8 in groups 2 
to 9, respectively as compared to group 1. The basophil (%) 
in normal rats was found to be zero. Therefore, basophil in 
treated groups (2-9) was not counted.      
The  haematological  study  conducted  in  the  present  work 
showed that EO altered levels of many parameters could be 
significantly  normalized  by  ProImmu  (150  mg/kg,  orally, 
daily  for  8  weeks);  however,  the  normalization  of  these 
parameters brought up by T. cordifolia (250 mg/kg, orally, 
daily for 8 weeks) and W. somnifera (250 mg/kg, orally, daily 
for  8  weeks)  was  found  to  be  of  lesser  degree.  Further, 
ProImmu  (150  mg/kg,  orally,  daily  for  12  weeks),  T. 
cordifolia  (250 mg/kg,  orally,  daily  for  12  weeks)  and  W. 
somnifera  (250  mg/kg,  orally,  daily  for  12  weeks)  also 
caused the normalcy of these parameters, but to less extent 
than observed on the 8 weeks. The findings of the present 
study  are  in  accordance  with  the  many  investigators.  The 
immunomodulatory effect of T. cordifolia was observed by 
earlier  workers
12.  The  methanolic  extract  (200  mg/kg,  ip, 
daily for 5 days) of T. cordifolia stem increased the humoral 
immune response and reduced solid tumour growth in mice
13. 
The  whole  plant  extract  of  W.  somnifera  possesses 
antioxidant,  antiinflammatory,  immunomodulating  and 
antistress  properties
14.  It  has  also  been  reported  that  W. 
somnifera  root  is  a  potential  source  of  hypoglycaemic, 
diuretic  and  hypocholesterolemic  drugs
15.  Methanol  and 
hexane extracts of leaves and roots of W. somnifera showed 
potent antibacterial activity as well
16; however, the leaf, root 
and  root  bark  of  this  herb  has  been  shown  to  possess 
antimalarial activity
17.  
 
CONCLUSION 
On the basis of haematological study, it can be concluded that 
ProImmu,  T.  cordifolia  and  W.  somnifera  possess  the 
cytogenic  effect,  which  is  time  dependent.  The  cytogenic 
effect of ProImmu may be due to its plant-ingredients, which 
have  been  reported  as  potent  immunostimulatory  and 
antioxidant  plants.  The  antioxidants  phytochemicals  cure 
many diseases by protecting the cells from damage caused by 
‘free radicals’- the highly reactive oxygen compounds. The 
cytogenic effects and mechanism of action of ProImmu, T. 
cordifolia and W. somnifera may be postulated on the basis 
of  their  immunostimulatory,  antioxidant,  phagocytic  and 
other cytoprotective activities.  
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